Navigating the Complexities of Predictive Biomarkers and Survival Endpoints

Interview with Julia Geronimi and Pavel Mozgunov

Why You Should Listen:

✔ You’ll learn a new method that’s both statistically sound and easy to implement

✔ You’ll see how to pre-specify your analysis strategy for biomarker evaluation

✔ You’ll understand how to get more value out of small sample sizes

✔ And you’ll come away with a fresh appreciation for the complexity—and opportunity—in biomarker-based trials

Resources & Links:

🔗 Read the full paper on this new biomarker approach

🔗 Connect with Julia Geronimi on LinkedIn

🔗 Connect with Pavel Mozgunov on LinkedIn

🔗 MRC Biostatistics Unit – University of Cambridge

🔗 The Effective Statistician Academy – I offer free and premium resources to help you become a more effective statistician.

🔗 Medical Data Leaders Community – Join my network of statisticians and data leaders to enhance your influencing skills.

🔗 My New Book: How to Be an Effective Statistician - Volume 1 – It’s packed with insights to help statisticians, data scientists, and quantitative professionals excel as leaders, collaborators, and change-makers in healthcare and medicine.

🔗 PSI (Statistical Community in Healthcare) – Access webinars, training, and networking opportunities.

If you’re working on evidence generation plans or preparing for joint clinical advice, this episode is packed with insights you don’t want to miss.

Join the Conversation:
Did you find this episode helpful? Share it with your colleagues and let me know your thoughts! Connect with me on LinkedIn and be part of the discussion.

Subscribe & Stay Updated:
Never miss an episode! Subscribe to The Effective Statistician on your favorite podcast platform and continue growing your influence as a statistician.